1 Conway G,Dewailly D,Diamantikandarakis E,et al.The polycystic ovary syndrome:a position statement from the European Society of Endocrinology.Eur J Endocrinol,2014,171:1-29. 2 Hifsa M,Nadeem A,Muhammad K.Polycystic Ovary Syndrome May Be an Autoimmune Disorder.Scientifica(Cairo),2016,2016:4071735. 3 Olszanecka-Glinianowicz M,Zachurzok A,Drosdzol-Cop A,et al.Circulating Anti-Müllerian Hormone Levels in Daughters of Women with and without Polycystic Ovary Syndrome.Horm Res in Paediatr,2016,85:372-378. 4 Barry JA,Azizia MM,Hardiman PJ.Risk of endometrial,ovarian and breast cancer in women with polycystic ovary syndrome:a systematic review and meta-analysis.Hum Reprod Update,2014,20:748-758. 5 Gottschau M,Kjaer SK,Jensen A,et al.Risk of cancer among women with polycystic ovary syndrome:A Danish cohort study.Gynecol Oncol,2015,136:99-103. 6 Glintborg D,Rubin KH,Nybo M,et al.Morbidity and medicine prescriptions in a nationwide Danish population of patients diagnosed with polycystic ovary syndrome.Eur J Endocrinol,2015,172:627-638. 7 Rubin KH,Glintborg D,Nybo M,et al.Fracture Risk Is Decreased in Women With Polycystic Ovary Syndrome:A Register-Based and Population-Based Cohort Study.J Bone Miner Res,2016,31:709-717. 8 Glintborg D,Andersen M.MANAGEMENT OF ENDOCRINE DISEASE:Morbidity in polycystic ovary syndrome.Eur J Endocrinol,2017,176:R53-R65. 9 Petríková J,Lazúrová I,Yehuda S.Polycystic ovary syndrome and autoimmunity.Eur J Inter Med,2010,21:369-371. 10 Kottyan LC,Zoller EE,Bene J,et al.The IRF5-TNPO3 association with systemic lupus erythematosus has two components that other autoimmune disorders variably share.Hum Mol Genet,2015,24:582-596. 11 Patel S.A critical review on serine protease:Key immune manipulator and pathology mediator.Allergol Immunopathol (Madr),2017,45:579-591. 12 Patel S.Disruption of aromatase homeostasis as the cause of a multiplicity of ailments:A comprehensive review.J Steroid Biochem Mol Biol,2017,168:19-25. 13 Karpuzoglu E,Schmiedt CW,Pardo J,et al.Serine protease inhibition attenuates rIL-12-induced GZMA activity and proinflammatory events by modulating the Th2 profile from estrogen-treated mice.Endocrinology,2014,155:2909-2923. 14 Holick MF.Vitamin D:A millenium perspective.J Cell Biochem,2003,88:296-307. 15 E.Wehr,Pilz S,Schweighofer N,et al.Interaction of 25-hydroxyvitamin D levels with metabolic characteristics in polycystic ovary syndrome.Bone,2009,44:357-358. 16 Muscogiuri G,Palomba S,Caggiano M,et al.Low 25 (OH) vitamin D levels are associated with autoimmune thyroid disease in polycystic ovary syndrome.Endocrine,2016,53:538-542. 17 Patel Seema.Polycystic ovary syndrome (PCOS),an inflammatory,systemic,lifestyle endocrinopathy.J Steroid Biochem Mol Biol,2018,182:27-36. 18 Dessein PH,Joffe BI.Insulin resistance and impaired beta cell function in rheumatoid arthritis.Arthritis Rheum,2014,54:2765-2775. 19 Xue Y,Xu P,Xue K,et al.Effect of vitamin D on biochemical parameters in polycystic ovary syndrome women:a meta-analysis.Arch Gynecol Obst,2017,295:1-10. 20 Fang F,Ni K,Cai Y,et al.Effect of vitamin D supplementation on polycystic ovary syndrome:A systematic review and meta-analysis of randomized controlled trials.Complement Ther Clin Pract,2017,26:53-60. 21 Joham AE,Teede HJ,Cassar S,et al.Vitamin D in polycystic ovary syndrome:Relationship to obesity and insulin resistance.Molec Nutrit Food Res,2016,60:110-118. 22 Muscogiuri G,Altieri B,De AC,et al.Shedding new light on female fertility:The role of vitamin D.Rev Endocr Metab Disord,2017:1-11. 23 Hefler-Frischmuth K,Walch K,Huebl W,et al.Serologic markers of autoimmunity in women with polycystic ovary syndrome.Fertil Steril,2010,93:2291-2294. 24 Reimand K,Talja I,Metsküla K,et al.Autoantibody studies of female patients with reproductive failure.J Reprod Immunol,2001,51:167-176. 25 Htet TD,Teede HJ,De CB,et al.Asthma in reproductive-aged women with polycystic ovary syndrome and association with obesity.Eur Respir J,2017,49:1601334. 26 Zierau L,Gade EJ,Lindenberg S,et al.Coexistence of asthma and polycystic ovary syndrome:A concise review.Respir Med,2016,119:155-159. 27 Cooper DS,Pearce EN.Subclinical Hypothyroidism and Hypothyroxinemia in Pregnancy - Still No Answers.N Engl J Med,2017,376:876-877. 28 Janssen OE,Mehlmauer N,Hahn S,et al.High prevalence of autoimmune thyroiditis in patients with polycystic ovary syndrome.Eur J Endocrinol,2004,150:363-369. 29 Petrikova J,Lazurova I,Dravecka I,et al.The prevalence of non-organ specific and thyroid autoimmunity in patients with polycystic ovary syndrome.Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub,2015,159:302-306. 30 Arduc A,Aycicek DB,Bilmez S,et al.High prevalence of Hashimoto's thyroiditis in patients with polycystic ovary syndrome:does the imbalance between estradiol and progesterone play a role? Endocr Res,2015,40:204-210. 31 Arora S,Sinha K,Kolte S,et al.Endocrinal and autoimmune linkage:Evidences from a controlled study of subjects with polycystic ovarian syndrome.J HumReprod Sci,2016,9:18-22. 32 Sinha U,Sinharay K,Saha S,et al.Thyroid disorders in polycystic ovarian syndrome subjects:A tertiary hospital based cross-sectional study from Eastern India.Indian J Endocrinol Metabol,2013,17:304-309. 33 Tagliaferri V,Romualdi D,Guido M,et al.The link between metabolic features and TSH levels in polycystic ovary syndrome is modulated by the body weight:an euglycemic-hyperinsulinemic clamp study.Eur J Endocrinol,2016,175:EJE-16-0358. 34 Glintborg D,Andersen M.Medical comorbidity in polycystic ovary syndrome with special focus on cardiometabolic,autoimmune,hepatic and cancer diseases:an updated review.Curr Opin Obstet Gynecol,2017,29:390-396. 35 Lebovitz HE.Adjunct therapy for type 1 diabetes mellitus.Nat Rev Endocrinol,2010,6:326-334. 36 Mezaal MI,Nader MI,Aziz IH.Molecular Study of Insulin Resistance and Polycystic Ovary Syndrome.Am J Med Med Sci,2015,5:121-125.
